We demonstrate that the silencing of megalin in the mouse brain endothelium is sufficient to increase the food intake, weight gain, and adiposity triggering hyperleptinemia, hyperinsulinemia, increased triglycerides blood levels, and impaired glucose tolerance. This evidence concerns the gene LRP2 and Hyperinsulinemia.